Literature DB >> 22817643

First and second generation antipsychotics influence hippocampal gamma oscillations by interactions with 5-HT3 and D3 receptors.

Steffen B Schulz1, Karin E Heidmann, Arpad Mike, Zin-Juan Klaft, Uwe Heinemann, Zoltan Gerevich.   

Abstract

BACKGROUND AND
PURPOSE: Disturbed cortical gamma band oscillations (30-80 Hz) have been observed in schizophrenia: positive symptoms of the disease correlate with an increase in gamma oscillation power, whereas negative symptoms are associated with a decrease. EXPERIMENTAL APPROACH: Here we investigated the effects of first and second generation antipsychotics (FGAs and SGAs, respectively) on gamma oscillations. The FGAs haloperidol, flupenthixol, chlorpromazine, chlorprothixene and the SGAs clozapine, risperidone, ziprasidone, amisulpride were applied on gamma oscillations induced by acetylcholine and physostigmine in the CA3 region of rat hippocampal slices. KEY
RESULTS: Antipsychotics inhibited the power of gamma oscillations and increased the bandwidth of the gamma band. Haloperidol and clozapine had the highest inhibitory effects. To determine which receptor is responsible for the alterations in gamma oscillations, the effects of the antipsychotics were plotted against their pK(i) values for 19 receptors and analysed for correlation. Our results indicated that 5-HT(3) receptors have an enhancing effect on gamma oscillations whereas dopamine D(3) receptors inhibit them. To test this prediction, m-chlorophenylbiguanide, PD 128907 and CP 809101, selective agonists at 5-HT(3) , D(3) and 5-HT(2C) receptors were applied and revealed that 5-HT(3) receptors indeed enhanced the gamma power whereas D(3) receptors reduced it. As predicted, 5-HT(2C) receptors had no effects on gamma oscillations. CONCLUSION AND IMPLICATIONS: Our data suggest that antipsychotics alter hippocampal gamma oscillations by interacting with 5-HT(3) and dopamine D(3) receptors. Moreover, a correlation of receptor affinities with the biological effects can be used to predict targets for the pharmacological effects of multi-target drugs.
© 2012 The Authors. British Journal of Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22817643      PMCID: PMC3514761          DOI: 10.1111/j.1476-5381.2012.02107.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  56 in total

Review 1.  A decade of progress in the discovery and development of 'atypical' antipsychotics.

Authors:  Gregor J MacDonald; José Manuel Bartolomé
Journal:  Prog Med Chem       Date:  2010

2.  Guidelines for reporting experiments involving animals: the ARRIVE guidelines.

Authors:  J C McGrath; G B Drummond; E M McLachlan; C Kilkenny; C L Wainwright
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Animal research: reporting in vivo experiments: the ARRIVE guidelines.

Authors:  Carol Kilkenny; William Browne; Innes C Cuthill; Michael Emerson; Douglas G Altman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 4.  Neuronal gamma-band synchronization as a fundamental process in cortical computation.

Authors:  Pascal Fries
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

Review 5.  Network mechanisms of gamma oscillations in the CA3 region of the hippocampus.

Authors:  Norbert Hájos; Ole Paulsen
Journal:  Neural Netw       Date:  2009-07-22

6.  Dysfunctional gamma-band activity during face structural processing in schizophrenia patients.

Authors:  Seung-Hwan Lee; Do-Won Kim; Eun-Young Kim; Sangrae Kim; Chang-Hwan Im
Journal:  Schizophr Res       Date:  2010-03-19       Impact factor: 4.939

Review 7.  Clozapine versus other atypical antipsychotics for schizophrenia.

Authors:  Claudia Asenjo Lobos; Katja Komossa; Christine Rummel-Kluge; Heike Hunger; Franziska Schmid; Sandra Schwarz; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

8.  Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.

Authors:  L Elliot Hong; Ann Summerfelt; Robert W Buchanan; Patricio O'Donnell; Gunvant K Thaker; Martin A Weiler; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

9.  N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.

Authors:  R S Ehrlichman; M J Gandal; C R Maxwell; M T Lazarewicz; L H Finkel; D Contreras; B I Turetsky; S J Siegel
Journal:  Neuroscience       Date:  2008-10-28       Impact factor: 3.590

Review 10.  Clozapine versus typical neuroleptic medication for schizophrenia.

Authors:  Adib Essali; Nahla Al-Haj Haasan; Chunbo Li; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more
  15 in total

1.  Fast gamma oscillations are generated intrinsically in CA1 without the involvement of fast-spiking basket cells.

Authors:  Michael T Craig; Chris J McBain
Journal:  J Neurosci       Date:  2015-02-25       Impact factor: 6.167

2.  5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation.

Authors:  April Johnston; Chris J McBain; André Fisahn
Journal:  J Physiol       Date:  2014-08-08       Impact factor: 5.182

3.  Layer- and area-specificity of the adrenergic modulation of synaptic transmission in the rat neocortex.

Authors:  Swagata Roychowdhury; Amy N Zwierzchowski; Francisco Garcia-Oscos; Roberto Cuevas Olguin; Roberto Salgado Delgado; Marco Atzori
Journal:  Neurochem Res       Date:  2014-09-30       Impact factor: 3.996

4.  Transcriptional dysregulation causes altered modulation of inhibition by haloperidol.

Authors:  Lillian J Brady; Aundrea F Bartley; Qin Li; Laura J McMeekin; John J Hablitz; Rita M Cowell; Lynn E Dobrunz
Journal:  Neuropharmacology       Date:  2016-07-29       Impact factor: 5.250

5.  Sustained Modafinil Treatment Effects on Control-Related Gamma Oscillatory Power in Schizophrenia.

Authors:  Michael J Minzenberg; Jong H Yoon; Yaoan Cheng; Cameron S Carter
Journal:  Neuropsychopharmacology       Date:  2015-09-02       Impact factor: 7.853

6.  Serotonin enhances excitability and gamma frequency temporal integration in mouse prefrontal fast-spiking interneurons.

Authors:  Jegath C Athilingam; Roy Ben-Shalom; Caroline M Keeshen; Vikaas S Sohal; Kevin J Bender
Journal:  Elife       Date:  2017-12-05       Impact factor: 8.140

7.  Resting-state gamma-band power alterations in schizophrenia reveal E/I-balance abnormalities across illness-stages.

Authors:  Tineke Grent-'t-Jong; Joachim Gross; Jozien Goense; Michael Wibral; Ruchika Gajwani; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Tobias Navarro Schröder; Dagmar Koethe; F Markus Leweke; Wolf Singer; Peter J Uhlhaas
Journal:  Elife       Date:  2018-09-27       Impact factor: 8.140

8.  Dopamine, cognitive function, and gamma oscillations: role of D4 receptors.

Authors:  Katrina E Furth; Surjeet Mastwal; Kuan H Wang; Andres Buonanno; Detlef Vullhorst
Journal:  Front Cell Neurosci       Date:  2013-07-02       Impact factor: 5.505

9.  Dopamine D3 Receptors Inhibit Hippocampal Gamma Oscillations by Disturbing CA3 Pyramidal Cell Firing Synchrony.

Authors:  Clément E Lemercier; Steffen B Schulz; Karin E Heidmann; Richard Kovács; Zoltan Gerevich
Journal:  Front Pharmacol       Date:  2016-01-06       Impact factor: 5.810

10.  NMDA-receptor inhibition and oxidative stress during hippocampal maturation differentially alter parvalbumin expression and gamma-band activity.

Authors:  Luisa A Hasam-Henderson; Grace C Gotti; Michele Mishto; Constantin Klisch; Zoltan Gerevich; Jörg R P Geiger; Richard Kovács
Journal:  Sci Rep       Date:  2018-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.